Researchers from the U.S. found a way to allow small substances to cross the blood-brain barrier and reach areas of the brain that are normally inaccessible. This means that drugs that are developed for the treatment of neurological conditions such as amyotrophic lateral sclerosis (ALS) could reach the brain and exert their activity.
Long-term use of Rilutek (riluzole) is associated with a better outcome in sporadic amyotrophic lateral sclerosis (ALS) patients, whereas short-term use seems to have little effect on survival according to a study published in the scientific journal Frontiers in Aging Neuroscience.
Among the various problems of life that families experience is the occasional exclusion of children from conversations. I remember hearing the older members of our family saying, “This is grown-folks’ business.” They’d tell us children to go outside and play. Depending on the age of a child, that might…
This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other present or future content posted by the contributor, not expressly designated as “Mitsubishi Tanabe Pharma America, Inc. – sponsored content” is not associated with MTPA. Linda is an actual patient…
Exposure to certain toxic airborne chemicals used in industry significantly increases — by up to six times — the odds of developing amyotrophic lateral sclerosis (ALS), a study suggests. Findings underscore the importance of surveillance programs testing exposure to these airborne pollutants, especially among populations at risk. The study,…
This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for U.S. audiences only. Any other present or future content posted by the contributor, not expressly designated as “Mitsubishi Tanabe Pharma America, Inc.-sponsored content” is not associated with MTPA. Albert is an actual patient who is…
This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for U.S. audiences only. Any other present or future content posted by the contributor, not expressly designated as “Mitsubishi Tanabe Pharma America, Inc. – sponsored content” is not associated with MTPA. Daniel is an actual patient…
Regulatory T-cells (Tregs) are a type of white blood cell that functions to suppress the body’s immune response and prevent unnecessary inflammation. Tregs are part of the immune system, and can also enter the brain and the spinal cord to reduce neuroinflammation. In amyotrophic lateral sclerosis (ALS) — a…
A Can lifestyle factors contribute to ALS? Category: Tregs Lifestyle factors such as military service, smoking, exposure to toxic chemicals, and strenuous exercise are risk factors for developing amyotrophic lateral sclerosis (ALS). Other possible risk factors include head trauma, electrical shock, and certain… Read More
A Has research shown a link between regulatory T-cells and ALS? Category: Tregs Research has made a link between decreasing regulatory T-cell (or Treg) levels in people with amyotrophic lateral sclerosis (ALS) and an increased rate of disease progression. Moreover, Tregs of ALS patients… Read More
Get regular updates to your inbox.